In recent years, Artificial Intelligence (AI) has been seen as one of the most disruptive forces in technology. But are the long-awaited advances in this area actually slowing down, or is a change in strategy needed to consolidate what has already been achieved? This question has been raised in several recently released sources.<\/p>\n
According to the Digital Look<\/a>, experts have questioned the slowdown in progress that many expected, especially in the quest for Artificial General Intelligence (AGI). The launch of OpenAI\u2019s ChatGPT nearly two years ago created a surge in expectations. Despite billions of dollars being invested by giants like OpenAI and Microsoft, it seems that more data and computing power alone are not enough. Gary Marcus, a well-known AI critic, describes the \u201cbigger is better\u201d strategy as a fantasy, since the promise that more data would organically result in AGI has not been realized.<\/p>\n On the other hand, while some see stagnation, others notice strategic changes. The Microsoft<\/a> continues to push the boundaries of AI with more pragmatic, productivity-focused solutions. With innovations such as autonomous agents integrated into Microsoft 365 and real-time voice translation in Teams, the tech giant appears to be focused on automation and efficiency in everyday corporate life. These are less bold advances, but they directly impact the daily lives of millions of professionals. The approach, which prioritizes efficiency and fluid connections between tools, could be a clue as to where AI is headed.<\/p>\n However, the world is not just watching: it is also regulating. At a recent G20 event in Rio de Janeiro, leaders stressed that while AI has tremendous potential for the digital economy, regulation is needed to mitigate potential risks. According to the Mobile Time<\/a>, the G20 discussed topics such as transparency in digital platforms and international data flows. But above all, the need for broad multinational governance was reinforced. The global regulatory dilemma is something that is already beginning to impact the pace of AI development.<\/p>\n When we look at areas like biotechnology, however, progress is still remarkable. The InvestNews<\/a> highlights that innovative algorithms called \u201ctransformative\u201d are opening new frontiers, especially in drug development. Companies like EvolutionaryScale show that this technology can be revolutionary in creating novel proteins, stimulating discoveries that could lead to new cures and biological therapies.<\/p>\n